Eyelid Scrub Market By Product Type (Wipes & Pads, Foams & Gels, Liquids); By Distribution Channel (Pharmacies, Online Retail, Clinics); By End User (Individual Consumers, Eye Clinics, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Eyelid Scrub Market is projected to reach a value of USD 674.2 million by 2030, up from an estimated USD 421.8 million in 2024, growing at a CAGR of 8.1% during 2024–2030, according to Strategic Market Research.

 

At first glance, eyelid scrubs may seem like a niche hygiene product. But beneath the surface, this category is evolving into a strategic health essential — sitting at the intersection of ophthalmology, dermatology, and personal care. These products, typically used to treat conditions like blepharitis, meibomian gland dysfunction (MGD), and dry eye disease, are seeing renewed demand thanks to changes in screen behavior, aging populations, and rising awareness of ocular hygiene.

 

What’s shifting? For starters, eye strain and digital device overuse are no longer just concerns for aging adults. Teens and young adults are now experiencing early signs of dry eye linked to screen-heavy lifestyles. Ophthalmologists are increasingly recommending preventive hygiene — including daily eyelid cleansing — alongside eye drops and other therapies. And consumer awareness is catching up. Once confined to clinics, eyelid scrubs are now available on pharmacy shelves and online marketplaces worldwide, often marketed as skincare-meets-eye-care.

 

From a clinical angle , blepharitis and MGD are chronic, recurring conditions. That creates a steady need for gentle, preservative-free cleaning solutions that don’t rely on prescription therapy. With antimicrobial resistance on the rise, many providers now prefer non-antibiotic, mechanical hygiene — and eyelid scrubs are filling that role.

 

From a consumer angle , there's been a wave of ingredient-focused innovation — think tea tree oil, hypochlorous acid, and micellar formulas. These formulations appeal not just to patients but to wellness-conscious consumers looking for holistic eye care routines. Some startups are even targeting the product as part of a broader “face hygiene” regimen.

 

The market is being shaped by several layers of stakeholders:

• Medical device firms and pharma-adjacent companies producing clinically validated scrub solutions

• Retail brands offering cosmetic-grade wipes and cleansers

• Ophthalmologists and optometrists pushing for proactive eye hygiene

• Retail pharmacies , online marketplaces , and eye clinics expanding access

• And increasingly, investors seeing stable margins in chronic-care, consumer-driven wellness products

To be honest , eyelid scrubs used to be an afterthought — prescribed when everything else failed. But with growing patient volumes, clinical data, and product sophistication, they’re becoming part of the first line of eye disease management. And the global consumer shift toward wellness and prevention? That’s only accelerating things.

 

Market Segmentation And Forecast Scope

The eyelid scrub market breaks down across multiple axes — each reflecting how different users prioritize comfort, convenience, efficacy, and access. These segments are no longer just about prescription vs. OTC; they now map onto a blend of clinical use, self-care habits, and product formats.

By Product Type

• Wipes & Pads: These account for the largest share of the market in 2024 , primarily due to their ease of use, portability, and wide availability. Patients prefer single-use formats for hygiene and convenience, especially during travel or in clinic settings. Major brands lead with sterile, pre-moistened solutions often infused with tea tree oil or hypochlorous acid.

• Foams & Gels: These are gaining traction fast, especially in ophthalmology clinics and among repeat users. Foams offer a preservative-free alternative with longer shelf lives and controlled dosing, which appeals to patients with chronic conditions like blepharitis or MGD.

• Liquids: Less commonly used in consumer channels but still relevant for prescription or specialty protocols. Some ophthalmologists recommend liquid cleansers to be applied with cotton pads — especially in severe or resistant cases.

Wipes dominate today, but foam-based formats are catching up quickly — particularly in Europe and North America where MGD and dry eye rates are highest.

 

By Distribution Channel

• Pharmacies & Drugstores: Still the go-to channel for medically endorsed eyelid hygiene products. These outlets cater to both prescription and OTC options, with strong pharmacist influence on consumer choice.

• Online Retail ( eCommerce): This is the fastest-growing channel by far. Brands are pushing direct-to-consumer (DTC) models, with auto-refill subscriptions, bundled eye care kits, and influencer-led product education. Amazon and brand-owned sites are now significant revenue generators.

• Ophthalmology Clinics & Specialty Practices: These serve as both point-of-care and point-of-sale. Clinics often stock physician-preferred brands that aren’t widely available in retail. These tend to be higher priced but trusted for chronic care.

Online platforms are driving broader adoption — especially in younger consumers who are new to eye hygiene and trust DTC wellness formats.

 

By End User

• Individual Consumers: This is the largest and most dynamic user group. The growth is driven by both patients with mild-to-moderate eye irritation and wellness-conscious consumers integrating eye hygiene into daily skincare routines.

• Ophthalmologists & Optometrists: These professionals are key influencers in product selection and brand trust. In many cases, doctors initiate patients into eyelid scrubs post-surgery, during MGD treatment, or as part of dry eye care protocols.

• Hospitals & Eye Care Centers: Used primarily in pre- and post-operative cleansing — especially in cataract and LASIK procedures where infection control is critical. Hospitals also use them for inpatient care among older adults with poor hygiene or chronic infections.

 

By Region

• North America: Currently holds the largest market share due to high awareness, easy access to over-the-counter products, and a large dry eye population.

• Europe: Second in share, but strong growth driven by increased recommendation from optometrists and rising adoption of tea tree–based eye hygiene routines.

• Asia Pacific: Fastest-growing region due to expanding middle-class healthcare spending, smartphone-induced eye strain, and a surge in digital retail adoption.

• Latin America & Middle East & Africa (LAMEA): Still developing in terms of awareness and product access, but gaining momentum through multinational pharmacy chains and affordable product launches.

Scope Note : The eyelid scrub market is evolving past traditional boundaries. What was once seen as a clinical adjunct is becoming a hybrid product category — living in both dermatology aisles and eye care clinics. Brands that understand this duality are the ones gaining market share fast.

 

Market Trends And Innovation Landscape

Innovation in the eyelid scrub market isn’t just about cleaner formulations — it’s about repositioning the product as a staple in both clinical care and consumer hygiene. Over the last three years, the space has shifted from niche eye treatment to an emerging sub-sector within wellness and personal care. Here's how the landscape is evolving.

Clinical Efficacy Meets Cosmetic Appeal

Traditionally, eyelid scrubs were targeted at patients with chronic conditions like blepharitis or dry eye. But the product narrative is changing. Brands now focus on dual benefits — therapeutic relief and cosmetic hygiene . That means soothing inflammation and removing eye makeup, oils, and debris. The result? More crossover between eye care and skincare, especially among female consumers aged 25–45.

Some companies now label eyelid scrubs as “ eyelid cleansers ” or “ lash hygiene foams ” to tap into broader appeal — including post-eyelash-extension care and acne-prone skin types.

 

Formulation Science: A Clean Label Arms Race

There’s a clear trend toward cleaner, safer, and more natural ingredients . Tea tree oil, micellar water, hypochlorous acid, and aloe vera are now common — replacing alcohol-heavy or preservative-rich formulations.

Hypochlorous acid , in particular, is gaining traction as an anti-inflammatory and antimicrobial compound that’s both gentle and effective. Products with 0.01–0.02% hypochlorous acid are now being marketed as suitable for daily, long-term use.

On the flip side, parabens, sulfates, and synthetic fragrances are being actively removed. This isn’t just for aesthetics — these compounds can worsen ocular surface diseases and limit long-term use.

 

AI-Powered Diagnostics Driving Adherence

Some ophthalmology clinics are integrating AI-based diagnostic tools that can visualize meibomian gland dysfunction in real time. Once diagnosed, physicians are recommending eyelid hygiene routines using branded scrubs — with app-based reminders and tracking to boost compliance.

One startup is even exploring smart mirror interfaces that remind users to perform daily eye cleansing — similar to tooth brushing. The idea: integrate eye care into routine wellness behavior through subtle nudges.

 

Teleophthalmology Is Fueling Home Use

As virtual eye exams and remote dry eye screenings rise, clinicians are leaning heavily on self-care protocols — and eyelid scrubs are one of the easiest to prescribe remotely. The market is seeing a surge in subscription-based home-use kits , often bundled with warm compress masks and lubricant eye drops.

These kits are especially popular among post-menopausal women and contact lens users — both high-risk groups for lid margin issues.

 

Cross-Sell Integration with Skincare and Cosmetics

A few savvy brands are beginning to bundle eyelid cleansers with makeup remover pads, micellar water, or lash serums . The message is subtle but powerful: your eye area needs dedicated hygiene, just like your skin.

One brand recently launched a lash-care trio pack — including a lash foam cleanser, conditioning serum, and makeup remover — targeting beauty-conscious consumers who wear mascara or lash extensions daily.

This move into beauty-adjacent territory is unlocking entirely new customer bases and reshaping marketing strategies from “medical need” to “daily wellness.”

 

Packaging and UX Are Finally Catching Up

The older eyelid scrub market was dominated by sterile wipes in medical packaging. That’s now changing. Foaming pumps , flip-cap bottles , and recyclable pouches are replacing single-use wipes. Some brands now emphasize “zero waste” routines and include washable cotton pads or silicone scrub tools.

Small detail, big payoff: one brand gained massive traction after redesigning their packaging to look like a high-end facial cleanser — and sales doubled in direct-to-consumer channels.

Bottom line: Innovation here isn’t just chemical. It’s experiential. Brands are blending clinical outcomes with lifestyle branding — and that’s expanding the use case from eye patients to everyday consumers.

 

Competitive Intelligence And Benchmarking

The eyelid scrub market is a mix of clinical eye care brands, personal care upstarts, and pharmacy-backed consumer goods companies — all competing in a space that now touches both therapeutic treatment and preventive wellness . But while there are many players, only a few are truly defining the strategic direction of this category.

Let’s break down the competitive landscape.

OCuSOFT

One of the most established names in the space, OCuSOFT dominates U.S. eye clinics with a portfolio focused entirely on eyelid hygiene. The company’s OCuSOFT Lid Scrub products — available in foam, pad, and pre-moistened forms — are often physician-recommended for managing blepharitis and meibomian gland dysfunction.

Their edge? Clinical trust. Most ophthalmologists trust OCuSOFT’s formulations, which include surfactant-based cleansers with antimicrobial action. They’ve also invested in physician education and direct clinic distribution , helping them hold their lead despite growing competition.

 

The Eye Doctor

A UK-based company that’s made inroads across Europe , The Eye Doctor offers eye care products that include heat masks and lid hygiene foam cleansers. Their positioning is anchored in dry eye symptom relief and MGD management , often marketed via optometrists.

What makes them stand out is their bundled offering — warm compresses + eyelid cleansers — creating a treatment protocol rather than just a product. They’re also focusing on pharmacy retail and eCommerce , which makes them well-placed in middle -income European and Asia Pacific markets.

 

Systane (Alcon)

Under the larger Alcon umbrella, Systane is known more for artificial tears — but has recently ventured into the lid hygiene segment. The company leverages its ophthalmic credibility to position its eyelid cleansing wipes as part of a complete dry eye system .

What’s notable is Alcon’s global footprint and regulatory strength . This gives Systane an advantage in entering regulated and emerging markets where OTC expansion still requires clinical backing.

 

Ocusoap and Oust Demodex

Brands like Ocusoap (USA) and Oust Demodex ( NovaBay ) cater to more severe cases, including Demodex infestations — a niche but increasingly recognized cause of lid margin disease. These brands position themselves at the clinical end of the spectrum, often sold through eye clinics or recommended by ophthalmologists.

Their differentiator is targeted treatment — not general hygiene. With the rise in AI-aided diagnostics that detect Demodex , these brands may grow even faster in the coming years.

 

Heyedrate

A newer, DTC-focused brand that operates with a strong online presence, Heyedrate markets organic eyelid cleansers and wellness kits through its own website and Amazon. The product lineup includes hypochlorous acid sprays , foams , and bundled dry eye kits.

Their strength? Customer education and subscription models . They offer detailed video guides, strong community engagement, and convenient monthly bundles — appealing to younger, wellness-savvy users.

 

Bruder Healthcare

Known primarily for its heat therapy masks , Bruder has also expanded into eyelid hygiene through its Hygiene Kit , which includes wipes and sprays. This integrated approach — pairing warm compresses with scrubs — aligns with current dry eye treatment protocols.

Their clinic relationships and retail pharmacy footprint position them well for bundled product sales, especially in North America.

 

Emerging Clean Beauty Brands

Several new players are entering the space via clean beauty and wellness , targeting skincare users rather than patients. These brands often focus on non-medicated lash cleansers , eye makeup removers, and botanical foam solutions — with packaging that looks more like Glossier than a clinic shelf.

One example includes a brand launching tea tree + micellar hybrid cleansers , co-branded with lash extension salons. Their goal? Make eyelid scrubs part of a daily lash - care routine — not just something you use when you're sick.

 

Competitive Summary at a Glance:

Company	Positioning	Channel Focus	Differentiator
OCuSOFT	Clinical/ophthalmologist preferred	Clinics, pharmacies	Longstanding clinical trust
The Eye Doctor	Dry eye treatment protocol	Pharmacies, eCom	Heat + hygiene kits
Systane (Alcon)	Ophthalmic system brand	Global pharmacy chains	Regulatory muscle, brand synergy
Heyedrate	DTC wellness-centric	Online direct	Subscription kits, strong community
Bruder	Dry eye kits	Clinics, retail	Integrated therapy model
Oust Demodex	Targeted treatment	Specialty clinics	Demodex -specific positioning

To be honest, market leadership in eyelid scrubs isn't just about being first — it's about being multi-channel, multi-use, and multi-audience . The brands gaining share are the ones that don’t force users to choose between medical and wellness — they meet them wherever they are, whether that’s in a clinic, a pharmacy, or on Instagram.

 

Regional Landscape And Adoption Outlook

Adoption of eyelid scrubs looks very different depending on where you are in the world. In some countries, they’re part of routine post-surgical eye care. In others, they’re a beauty add-on or simply unavailable. What’s emerging is a global split — between markets where eyelid hygiene is becoming mainstream , and those where awareness still lags.

Let’s break it down.

North America

This is the most mature and commercially diverse region. The U.S. and Canada lead in both clinical adoption and consumer awareness. Ophthalmologists regularly prescribe eyelid scrubs for conditions like blepharitis, MGD, and dry eye , especially in patients over 40 and post-surgery. Clinical brands like OCuSOFT and Systane dominate, but DTC players like Heyedrate are gaining ground.

Retail pharmacies and online platforms have made access easy, and there's been strong convergence between medical and consumer messaging — “clean your eyelids like you clean your face” is becoming a common pitch.

There’s also growing demand among eyelash extension users , contact lens wearers, and screen-heavy younger adults — all driving broader daily use beyond the clinic.

 

Europe

Adoption here is driven by optometrist recommendation and national pharmacy networks . The UK, Germany, and France are key markets. Brands like The Eye Doctor and Bruder have strong visibility in pharmacy chains and optical retail clinics.

In many parts of Europe, eyelid scrubs are part of a broader dry eye protocol , especially when combined with heat therapy and artificial tears . Public reimbursement is limited, but the self-pay market is strong — particularly among aging adults and digital workers.

France and Scandinavia are also seeing a rise in clean beauty positioning , where eyelid foams are sold as micellar-based lash cleansers in beauty pharmacies and natural health stores.

 

Asia Pacific

This is the fastest-growing region , but adoption varies wildly. Japan and South Korea have high consumer awareness and spend heavily on eye and lash hygiene — not just for health but also aesthetics. Skincare-first cultures here are already used to multi-step routines, so incorporating eyelid scrubs is relatively frictionless.

In China and India , clinical adoption is growing fast, especially in urban ophthalmology clinics treating dry eye and post-LASIK patients. However, access in tier-2 and rural cities is still low. That’s where eCommerce is playing a pivotal role, with brands now offering affordable foam kits online , often bundled with heat masks and eye drops.

Teleconsultation is also gaining ground in these markets — and with it, remote prescription of hygiene routines , especially for contact lens users and allergy-prone adolescents.

 

Latin America

Still emerging, but there are pockets of growth. Brazil and Mexico are leading in dry eye treatment innovation and have begun integrating eyelid scrubs into pre- and post-surgical care . Pharmacy chains in major cities are expanding their eyelid and lash hygiene sections , but access in rural areas remains limited.

Local awareness campaigns are beginning to highlight the role of Demodex mites and eyelid hygiene in managing chronic eye irritation — this education gap is likely to fuel future demand.

 

Middle East & Africa

The least penetrated region, but not without potential. UAE and Saudi Arabia are investing in advanced ophthalmology clinics and cosmetic procedures, where eyelid hygiene is part of surgical prep and recovery. Eye care centers here often stock imported U.S. and European eyelid scrub brands.

In contrast, sub-Saharan Africa has extremely limited access to these products, and the market is still nascent. NGO-led vision programs may eventually introduce basic hygiene protocols — but commercial adoption is likely years away without structural investment.

 

Key Regional Themes

• North America leads in multi-channel availability and prescription-backed trust.

• Europe balances professional guidance with beauty-store retail expansion.

• Asia Pacific is scaling fast, with eCommerce and beauty driving both clinical and lifestyle demand.

• Latin America is moving slowly but shows strong adoption potential in urban health systems.

• Middle East & Africa remain early-stage — but select Gulf countries show surprising sophistication.

Bottom line: The eyelid scrub market isn’t globally saturated — it’s just beginning to stratify. Mature markets are driving innovation, while emerging ones offer room for basic awareness- building and access expansion. The brands that win regionally are those that adapt to how consumers view eye care — either as medical therapy, lifestyle hygiene, or both.

 

End-User Dynamics And Use Case

The eyelid scrub market has a unique characteristic: it cuts across clinical treatment, self-care, and even cosmetic maintenance. Each end user — whether a hospital, a specialty eye clinic, or a consumer — uses these products in slightly different ways, driven by need, frequency, and setting. Understanding these end-user behaviors is critical to understanding where growth is coming from.

Ophthalmology Clinics & Optometrists

These are still the primary prescribers and educators in the space. In patients diagnosed with meibomian gland dysfunction (MGD) , blepharitis , or post-cataract surgery inflammation , eyelid scrubs are often the first line of non-pharmacologic therapy .

Clinicians typically favor brands with a track record in clinical studies — like OCuSOFT or Alcon's Systane wipes. Usage here is consistent and medically driven, and often paired with other therapies like warm compresses or artificial tears.

Clinics also act as point-of-sale. They sell these products directly to patients — which helps with compliance but also boosts recurring revenue for the practice.

 

Hospitals and Surgical Centers

In hospitals and ambulatory surgical centers (ASCs) , eyelid scrubs are primarily used pre- and post-operatively , particularly for procedures involving intraocular lenses (IOLs), LASIK, or PRK. The goal is to reduce microbial load on the lid margins to prevent infection.

Hospitals usually purchase in bulk or sterile packaging formats , with preference for non-irritating, preservative-free formulas that reduce post-op complications. Adoption here is highly protocolized — meaning once a hospital standardizes around a product, it tends to stick for years.

 

Retail Pharmacies and Eye Care Stores

Retail is where product visibility — not just efficacy — drives use. Consumers with mild symptoms or no diagnosis often start here. Most pick up wipes or foam cleansers out of curiosity, recommendation, or as an add-on to their dry eye or contact lens regimen.

Retail buyers tend to look for:

• Easy-to-use formats (no cotton pads or rinse steps)

• Ingredient clarity ( hypochlorous acid, tea tree oil, etc.)

• Comfort — no stinging or strong fragrances

This channel is especially important for first-time buyers who may never see a doctor but still need basic hygiene support.

 

Online Consumers (DTC Buyers)

This is arguably the most behaviorally diverse end-user segment. Some are post-LASIK patients reordering products online. Others are skincare enthusiasts or lash extension users looking for gentle lid cleansers. Many are trying these products for digital eye strain or cosmetic hygiene — without ever thinking of them as "medical."

What’s common across this group is:

• Subscription models are attractive

• Educational content drives loyalty

• Trust is built through reviews, not doctors

These users are reshaping the category — turning it into part of a preventive self-care routine rather than a disease-specific protocol.

 

Use Case Highlight

A private ophthalmology center in Melbourne noticed that 60% of its dry eye patients were non-compliant with warm compress routines. Many cited discomfort, lack of time, or forgetting. In response, the clinic introduced a simple, two-step eyelid hygiene kit — a branded foam scrub plus a pre-heated Bruder mask — and started offering it at check-out.

Within 3 months, return visits improved, symptom scores dropped by 30%, and online re-orders increased fivefold. Interestingly, several patients began using the scrub even after symptoms resolved — simply because they liked the "fresh feeling" after removing makeup or screen time.

This reflects a broader insight: when hygiene products offer comfort, not just treatment, adherence stops being a problem.

Bottom line: end users are shifting from reactive to proactive , and from medically directed to self-initiated . The brands that understand how to serve both ends of that spectrum — the clinic and the bedroom mirror — are the ones carving out long-term loyalty.

 

Recent Developments + Opportunities & Restraints

The eyelid scrub market has seen more movement in the last two years than in the previous decade. What was once a slow-moving segment dominated by legacy clinic brands is now being reshaped by new entrants , ingredient reformulation , multi-channel expansion , and growing consumer awareness . Here's a rundown of what’s changed — and what’s coming next.

Recent Developments (2023–2025)

• OCuSOFT launched a new preservative-free foam scrub line in mid-2024, featuring an updated formula with tea tree extract and micellar cleansing agents. The company emphasized improved comfort for long-term use and reduced eye irritation.

• In early 2024, Alcon extended its Systane brand to include lid cleansing wipes specifically formulated for post-LASIK patients, positioning the product as part of a complete surgical aftercare package.

• Bruder Healthcare debuted an updated Dry Eye Relief Kit , bundling its heated mask with a hypochlorous -based lid hygiene spray. This launch was backed by targeted campaigns in optometry journals and pharmacy training programs.

• Heyedrate introduced a DTC subscription box in 2023 that includes monthly refills of its foaming cleanser, warming mask, and omega-3 dry eye supplements. Their influencer-led education strategy saw a 3x sales lift across Instagram and TikTok channels.

• In 2025, a Korean startup released a dual-phase lash cleanser for both makeup removal and lid hygiene — targeting consumers who use eyelash extensions or suffer from recurring styes . The product is now gaining traction in Southeast Asia’s online beauty markets.

 

Opportunities

• Mainstreaming into Personal Care: The single biggest unlock for this market? Turning eyelid scrubs into a skincare staple . With the rise of facial cleansers, toners, and micellar waters, consumers are already trained to think about cleansing routines. Positioning eyelid hygiene as the "missing step" in facial care could drive adoption in consumers without any diagnosed eye condition.

• Expansion into Emerging Markets: Urban centers in India, Indonesia, and Brazil are experiencing a rise in both dry eye symptoms and digital fatigue. However, ophthalmologist access remains uneven. This creates an opening for affordable, over-the-counter scrub products , sold via pharmacies or eCommerce platforms — especially when paired with heat masks or eye drops.

• Pairing with AI Diagnostics in Eye Clinics: As clinics adopt AI-based tear film and MGD diagnostics , there's a growing push to standardize hygiene-first protocols . That opens the door for clinic-private label kits that include branded scrubs, which patients are more likely to buy if linked to visual test results showing inflammation or gland blockage.

 

Restraints

• Lack of Consumer Awareness Outside Clinical Settings: Despite growth, many consumers still have no idea what eyelid scrubs are — or confuse them with cosmetic removers. The absence of consistent education at the retail level (pharmacies, online stores) slows down casual adoption. Without clear messaging, even well-formulated products can get buried under skincare or eye drop noise.

• Price Sensitivity in Cost-Conscious Markets: Products with clean ingredients and clinical backing tend to be priced above everyday cleansers. In markets without insurance reimbursement or bundled eye care programs , this pricing gap can be a real barrier — especially for chronic users who need to cleanse daily.

 

7.1. Report Coverage Table

Report Attribute	Details
Forecast Period	2024 – 2030
Market Size Value in 2024	USD 421.8 Million
Revenue Forecast in 2030	USD 674.2 Million
Overall Growth Rate	CAGR of 8.1% (2024 – 2030)
Base Year for Estimation	2024
Historical Data	2019 – 2023
Unit	USD Million, CAGR (2024 – 2030)
Segmentation	By Product Type, Distribution Channel, End User, Geography
By Product Type	Wipes & Pads, Foams & Gels, Liquids
By Distribution Channel	Pharmacies, Online Retail, Clinics
By End User	Individual Consumers, Eye Clinics, Hospitals
By Region	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country Scope	U.S., UK, Germany, China, India, Japan, Brazil, etc.
Market Drivers	- Increased screen-related eye strain - Expansion of DTC and eCommerce channels - Growth in preventive hygiene awareness
Customization Option	Available upon request